Abstract: Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralize NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis and cancer.

Abstract: Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralise NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis and cancer.

Abstract: Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralize NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis and cancer.

Abstract: Protein variants of CTLA-4, which show increased activity compared to wild-type in a cell assay and which exhibit increased stability. Such variants are useful for treatment of disorders whereby attenuation of the T cell response would be beneficial.

Abstract: Protein variants of CTLA-4, which show increased activity compared to wild-type in a cell assay and which exhibit increased stability. Such variants are useful for treatment of disorders whereby attenuation of the T cell response would be beneficial.

Abstract: Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralise NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis and cancer.

Abstract: A personal item storage tray which includes a storage surface that incorporates a personal item identification, placement, retention, storage and removal apparatus or structure. One embodiment includes a substantially planar arrangement of depressions or recessed compartments designed to receive specific personal items such as, for example, eyeglasses, hearing aids and dentures. The compartments may be uniquely designed, shaped and marked to signal the uses of the compartment and to distinguish each compartment from the other to aid in visual identification and discrimination between the uses of each recessed compartment. The presence of items in the compartments is used to signal to the users of the tray that items are accounted for and not missing. The bottom surface of the tray includes a non-skid surface to avoid accidental or undesirable lateral movement. The tray is designed with a moldable or shapeable material.

Abstract: A personal item storage tray which includes a storage surface that incorporates a personal item identification, placement, retention, storage and removal apparatus or structure. One embodiment includes a substantially planar arrangement of depressions or recessed compartments designed to receive specific personal items such as, for example, eyeglasses, hearing aids and dentures. The compartments may be uniquely designed, shaped and marked to signal the uses of the compartment and to distinguish each compartment from the other to aid in visual identification and discrimination between the uses of each recessed compartment. The presence of items in the compartments is used to signal to the users of the tray that items are accounted for and not missing. The bottom surface of the tray includes a non-skid surface to avoid accidental or undesirable lateral movement. The tray is designed with a moldable or shapeable material.

Abstract: A personal item storage tray which includes a storage surface that incorporates a personal item identification, placement, retention, storage and removal apparatus or structure. One embodiment includes a substantially planar arrangement of depressions or recessed compartments designed to receive specific personal items such as, for example, eyeglasses, hearing aids and dentures. The compartments may be uniquely designed, shaped and marked to signal the uses of the compartment and to distinguish each compartment from the other to aid in visual identification and discrimination between the uses of each recessed compartment. The presence of items in the compartments is used to signal to the users of the tray that items are accounted for and not missing. The bottom surface of the tray includes a non-skid surface to avoid accidental or undesirable lateral movement. The tray is designed with a moldable or shapeable material.